Aortic Valve Insufficiency Recruiting Phase 4 Trials for Rivaroxaban (DB06228)

Also known as: Aortic Valve Incompetence / Aortic Regurgitation / Insufficiency, Aortic Valve / Aortic incompetence

IndicationStatusPhase
DBCOND0000570 (Aortic Valve Insufficiency)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02974920Rivaroxaban or Aspirin for Biological Aortic ProsthesisPrevention